Brosch, Philippa K.Philippa K.BroschKorsa, TessaTessaKorsaTaban, DanushDanushTabanEiring, PatrickPatrickEiringHildebrand, SaschaSaschaHildebrandNeubauer, JuliaJuliaNeubauerZimmermann, HeikoHeikoZimmermannSauer, Markus H.M.Markus H.M.SauerShirakashi, RyoRyoShirakashiDjuzenova, Cholpon S.Cholpon S.DjuzenovaSisario, DmitriDmitriSisarioSukhorukov, Vladimir L.Vladimir L.Sukhorukov2023-08-182023-08-182022https://publica.fraunhofer.de/handle/publica/44839710.3390/cancers142357942-s2.0-85143590213(1) Background: The recurrence of glioblastoma multiforme (GBM) is mainly due to invasion of the surrounding brain tissue, where organic solutes, including glucose and inositol, are abundant. Invasive cell migration has been linked to the aberrant expression of transmembrane solute-linked carriers (SLC). Here, we explore the role of glucose (SLC5A1) and inositol transporters (SLC5A3) in GBM cell migration. (2) Methods: Using immunofluorescence microscopy, we visualized the subcellular localization of SLC5A1 and SLC5A3 in two highly motile human GBM cell lines. We also employed wound-healing assays to examine the effect of SLC inhibition on GBM cell migration and examined the chemotactic potential of inositol. (3) Results: While GBM cell migration was significantly increased by extracellular inositol and glucose, it was strongly impaired by SLC transporter inhibition. In the GBM cell monolayers, both SLCs were exclusively detected in the migrating cells at the monolayer edge. In single GBM cells, both transporters were primarily localized at the leading edge of the lamellipodium. Interestingly, in GBM cells migrating via blebbing, SLC5A1 and SLC5A3 were predominantly detected in nascent and mature blebs, respectively. (4) Conclusion: We provide several lines of evidence for the involvement of SLC5A1 and SLC5A3 in GBM cell migration, thereby complementing the migration-associated transportome. Our findings suggest that SLC inhibition is a promising approach to GBM treatment.enphlorizintransportomevolume regulationjournal article